Donanemab: FDA experts recommend approval of Alzheimer ' s drug

被引：7

|

作者：

Dyer, Owen

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2024年 / 385卷

关键词：

D O I：

10.1136/bmj.q1327

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：2

相关论文

共 50 条

[21] DRUG APPROVAL PROCESS AND FDA
SCHMIDT, AM
NEW YORK STATE JOURNAL OF MEDICINE, 1976, 76 (12) : 2039 - 2042
[22] Donanemab (Kisunla) for Alzheimer's Disease
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1709):
[23] Biogen seeks approval of Alzheimer's drug
Jarvis, Lisa M.
CHEMICAL & ENGINEERING NEWS, 2019, 97 (42) : 10 - 10
[24] FDA Approval of Aduhelm Paves a New Path for Alzheimer's Disease
Tanzi, Rudolph E.
Rose, Joseph. P.
Kennedy, F.
ACS CHEMICAL NEUROSCIENCE, 2021, 12 (15): : 2714 - 2715
[25] Agents at the Peak of US FDA Approval for the Treatment of Alzheimer's Disease
Alam, Jahngeer
Kalash, Anushka
Hassan, Md Imtaiyaz
Rahman, Syed Ziaur
NEUROLOGICAL RESEARCH, 2024, 46 (04) : 318 - 325
[26] Rivastigmine transdermal system receives FDA approval for Alzheimer's disease
Ralat, Jose
CNS SPECTRUMS, 2007, 12 (08) : 581 - 582
[27] FDA approval for Biogen’s aducanumab sparks Alzheimer disease firestorm
Asher Mullard
Nature Reviews Drug Discovery, 2021, 20 : 496 - 496
[28] FDA approval for Biogen's aducanumab sparks Alzheimer disease firestorm
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (07) : 496 - 496
[29] FDA's Expedited Approval Mechanisms for New Drug Products
Kepplinger, Erin E.
BIOTECHNOLOGY LAW REPORT, 2015, 34 (01) : 15 - 37
[30] Lecanemab: European drug agency upholds decision to recommend Alzheimer's drug
Wise, Jacqui
BMJ-BRITISH MEDICAL JOURNAL, 2025, 388

← 1 2 3 4 5 →